Abstract
Abstract nos: 638-640 TCT-638Five-year Clinical Outcomes of Drug Eluting Stents Versus Bare Metal Stents inPatients With Large Vessel and Single Coronary LesionKyuhwan Park 1 , Chan-Hee Lee , Yoon Jung Choi 1 , Tae Hun Kwon , Kanguni Choi ,Jang Won Son 1 , Sang-Hee Lee , Ung Kim , Jong Seon Park 1 , Dong-Gu Shin 1 ,Young-Jo Kim 1 , Jeong-Hwan Cho 2 , Sang Wook Kang 2 , Yoon-Kyung Cho 3 ,Hyungseop Kim 3 , Chang-Wook Nam , Seung-Ho Hur 3 , Kwon-Bae Kim ,Dong-Kie Kim 4 , Sang-Hoon Seol , Tae-Hyun Yang1Yeungnam University Medical Center, Daegu, Korea, Republic of, 2 Daegu VeteransHospital, Daegu, Korea, Republic of, 3 Keimyung University Dongsan Medical Center,Daegu, Korea, Republic of, 4 Inje University Haeundae Paik Hospital, Busan, Korea,Republic ofBackground: The aim of this study is to evaluate long term clinical outcomes of drug-eluting stent (DES) and bare metal stent(BMS) with large vessel diameter and singlecoronary lesions for 5 years.Methods: Atotalof428consecutivepatientswhovisited3medicalcentersfromMarch2003toApril2007andhadasinglecoronarylesionwhichwastreatedwiththeuseofaDESorBMSthatwasmorethan3.5mmindiameterwereenrolledinthisstudy.Patientsweredividedinto2stentgroups:DES(n¼299),BMS(n¼129).Thestudyendpointwasa composite of major adverse cardiac events (MACE) including death, myocardialinfarction (MI), and target-vessel revascularization (TVR) for five yearsResults: Baseline characteristics were not different. 5 years follow up rate was 82.5%(355/428). The cumulative MACE rate for 5 years were not different between twogroup ( 20.4% in BMS vs. 18% in DES, p¼0.592). The rate of MI (3.1% in BMS vs.2.4% in DES, p¼0.513), death (3.7% in BMS vs. 2.0% in DES, p¼0.361) and TVR(12% in BMS vs. 10.6% in DES, p¼0.694) were not different. There was no dif-ference in MACE-free survival rate between the DES group and the BMS group(93.1% in DES vs 90.7% in BMS, P¼0.472).Conclusions: Clinical outcomes between DES and BMS are similar in a large vesseldiameter and single coronary arterial lesion for 5 years.TCT-639Impact Of The Length Of Bare Metal Stent On Clinical Events AfterPercutaneous Coronary Intervention In Current Clinical PracticeIgnacio Sanchez-Perez
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have